Correlation of magnetization transfer ration with clinical disability in multiple sclerosis

Annals of Neurology

Volumn 36, Issue 1, 1994, Pages 62-67

  Gass, A ^a   Barker, G J ^a   Kidd, D ^a   Thorpe, J W ^a   MacManus, D ^a   Brennan, A ^a   Tofts, P S ^a   Thompson, A J ^a   McDonald, W I ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; DISABILITY; HUMAN; IMAGE ANALYSIS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; VASCULAR DISEASE;

ADULT; AGED; AXONS; BRAIN; FEMALE; HUMAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; MYELIN SHEATH; RECURRENCE; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T;

EID: 0028359213     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410360113     Document Type: Article

References (36)

1. Nuclear magnetic resonance imaging of the brain in multiple sclerosis
2. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study
3. MRI in the diagnosis of MS: a prospective study and comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT
4. Benigh versus chronic progressive multiple sclerosis: magnetic resonance imaging features
5. Serial gadolinium enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration
6. Patterns of disease activity in multiple sclerosis: a clinical and magnetic resonance imaging study
7. The pathological evolution of multiple sclerosis
8. Cross relaxation and spin diffusion in the proton NMR of hydrated collagen
9. Magnetisation transfer contrast (MTC) and tissue water proton relaxation in vivo
10. Magnetization transfer contrast in magnetic resonance imaging
11. Balaban RS. Quantitative H magnetisation transfer imaging in vivo
12. Expermental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging
13. New diagnostic criteria for multiple sclerosis: guidelines for research protocols
14. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
15. Major differences in the dynamics of primary and secondary multiple sclerosis
16. Volume measurement of multiple sclerosis lesions with magnetic resonance images: a preliminary study
17. Dynamic and chemical factors affecting water proton relaxation by macromolecules
18. Lipid bilayer and water proton magnetisation transfer: effect of cholesterol
19. Design and implementation of MT pulse sequences for clinical use
20. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination
21. Distribution of sodium channels in chronically demyelinated spinal cord axons: immuno‐ultrastructural localization and electrophysiological observations
22. Conduction in the optic nerve
23. The optic nerve in multiple sclerosis: a morphological study with retrospective clincopathlogical correlation
24. Course and prognosis of multiple sclerosis
25. White‐matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis
26. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations
27. Pathological correlates of increased signal of the centrum ovale on magnetic resonance imaging
28. Demyelinating diseases
29. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
30. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis
31. Precise relaxation time measurements of normal appearing white matter in inflammatory central nervous system disease
32. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis
33. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines
34. Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis
35. The UBC MS/MRI Study Group, IFNB Multiple Sclerosis Study Group. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double‐blind, placebo‐controlled trial